Development and progression of hepatic steatosis during long-term glucocorticoid therapy in autoimmune hepatitis: multimodal evidence from biopsy, CAP, and ultrasound
{{output}}
Introduction: Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease treated with glucocorticoids (GCs). Long-term GCs therapy may increase the risk of hepatic steatosis. This study aimed to evaluate the impact of pro... ...
